Clinical Experience in Treatment of Alzheimer’s Disease with Jiannao Yizhi Formula (健脑益智方) and Routine Western Medicine
- 16 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Chinese Journal of Integrated Medicine
- Vol. 26 (3), 212-218
- https://doi.org/10.1007/s11655-019-2718-2
Abstract
Abstract Objective To investigate the long-term therapeutic effects of the Chinese medicine Jiannao Yizhi Formula (健脑益智方, JYF) in the treatment of Alzheimer’s disease (AD). Methods Sixty mild-to-moderate AD participants were recruited and randomly allocated to the treatment (30 with JYF) and the control groups (30 with donepezil) for 6 months with the random numbers. The primary outcomes were scores of Alzheimer’s Disease Rating Scale-Cognitive (ADAS-Cog) and Chinese Medicine Symptom Scale (CM-SS). The secondary outcomes were scores of Mini Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and Activities of Daily Living (ADL). Safety assessments were conducted at baseline and the 6th month of treatment. Serum levels of acetylcholine (Ach), amyloid-β protein 42 (Aβ42), and the microtubule-associated protein tau (Tau) were also determined by enzyme-liked immunosorbent assay. Results Fifty-one participants were included in the final analyses (JYF n=27; donepezil n=24). Compared with baseline, both JYF and donepezil increased the MoCA and MMSE scores and decreased the ADAS-Cog and CM-SS scores (PP42 and Tau (all P Conclusion The effect and safety of JYF for the treatment of AD were not inferior to those of donepezil.Keywords
This publication has 31 references indexed in Scilit:
- Cerebrovascular disease in ageing and Alzheimer’s diseaseActa Neuropathologica, 2015
- Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical TrialJournal of Clinical Oncology, 2015
- A Potent Multi-functional Neuroprotective Derivative of TetramethylpyrazineJournal of Molecular Neuroscience, 2015
- New criteria for Alzheimer’s disease: which, when and why?Brain, 2015
- Cerebrospinal fluid and plasma biomarkers in Alzheimer diseaseNature Reviews Neurology, 2010
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2005
- Phases of Aβ-deposition in the human brain and its relevance for the development of ADNeurology, 2002
- A new rating scale for Alzheimer's diseaseAmerican Journal of Psychiatry, 1984
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975